ETON - Eton Pharmaceuticals Inc.'s (ETON) CEO Sean Brynjelsen on Q1 2021 Results - Earnings Call Transcript

Eton Pharmaceuticals, Inc. (ETON) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants David Krempa – Senior Vice President-Business Development and Investor Relations Sean Brynjelsen – Chief Executive Officer James Gruber – Chief Financial Officer Conference Call Participants Mitchell Kapoor – H. C. Wainwright Justin Walsh – B. Riley Presentation Operator Good afternoon. And welcome to the Eton Pharmaceuticals’ First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company's request. At this time, I’d like to turn it over to David Krempa, Senior Vice President of Business Development and Investor Relations at Eton Pharmaceuticals. Please proceed. David Krempa Thank you, operator. Good afternoon, everyone. And welcome to Eton’s first quarter 2022 conference call. This

For further details see:

Eton Pharmaceuticals, Inc.'s (ETON) CEO Sean Brynjelsen on Q1 2021 Results - Earnings Call Transcript